March 26 - 28, 2020
Chicago Marriott Downtown Magnificent Mile
Chicago, IL

Register by December 16 to Save $200!

Accreditation

Jointly provided by Postgraduate Institute for Medicine and Global Academy for Medical Education. The American Board of Psychiatry and Neurology has reviewed the Current Psychiatry/AACP 2020 Psychiatry Update and has approved this program as part of a comprehensive CME program, which is mandated by the ABPN as a necessary component of maintenance of certification (MOC). The activity awards 22 AMA PRA Category 1 Credits(including post-conference workshops) and 8 Self-Assessment Category 1 CME credits.

 

Target Audience:
This activity is intended for pediatric,
general and geriatric psychiatrists, nurse practitioners, physician assistants, nurses, psychologists, social workers and other mental health professionals engaged in the care of patients with ADHD, Alzheimer’s Disease, Women’s Mental Health, Depression, Psychosis, Hallucinations, Adult and Pediatric Anxiety and Mood Disorders, College Mental Health, Addiction, Geriatric Psychiatry, Insomnia and Sleep Disorders, and Personality Disorder.

 

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education:
The Postgraduate Institute for Medicine designates this live activity for a maximum of 22 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education:
The maximum number of hours awarded for this Continuing Nursing Education activity is 22 contact hours. Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined

NURSES

 

 

Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 22 (18 for the general sessions and 4 for attending the pre-conference workshops) contact hours. Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined and will be indicated on your certificate.

Individual Session Learning objectives

At the conclusion of this activity, clinicians should be better able to:

  • Explain the neurobiology of addiction and how it can inform treatment.
  • Delineate special needs and issues related to the pregnant addicted patient, adolescent and elderly addicted populations, and patients with comorbid psychiatric disorders.
  • Describe the pharmacology of cannabis and the formulations used for medical purposes.
  • Discuss current state of the evidence for the therapeutic use of cannabis.
  • Describe the acute and chronic risks of cannabis use.
  • Illustrate strategies to implement medical cannabis safely and effectively into clinical practice.
  • List serious medical side effects of antipsychotic agents.
  • Develop appropriate monitoring strategies for patients receiving antipsychotic medications.
  • List patient characteristics that are more indicative of bipolar versus unipolar depression.
  • Distinguish between the mechanisms of action of available antipsychotic agents to develop appropriate treatment strategies.
  • Develop a systematic approach to the evaluation of sleep disorders.
  • Outline the spectrum of treatment modalities for sleep disorders and integrate practice guidelines for their treatment.
  • Discuss the bidirectional relationship between sleep disorders and psychiatric disorders.
  • Discuss anxiety disorders in youth and their treatments.
  • Describe how inflammatory brain conditions may cause acute anxiety disorders.
  • Recognize depressive and bipolar disorders in youth.
  • Develop psychotherapeutic and pharmacologic treatment strategies for youth with mood disorders.
  • Strategize the optimal treatment approach to psychiatric illness in women currently pregnant or intending to become pregnant.
  • Frame the treatment of psychiatric disorders during pregnancy from the standpoint of reproductive safety when considering pharmacotherapies.
  • Identify multiple and patient-centered variables in treatment selection for pregnant and reproductive-aged women with psychiatric disorders.
  • Develop strategies for screening and treatment of perinatal or postpartum depression and mood episodes in women with bipolar disorder.
  • List risks, benefits, safety of psychiatric medication during the postpartum and breastfeeding periods.
  • Explain the presentation and treatment of postpartum psychosis.
  • Explain the clinical correlates of neuroinflammation in schizophrenia and psychotic episodes
  • Interpret the studies of adjunctive anti-inflammatory agents in acute psychosis.
  • Analyze the role of auditory and other hallucinations in clinical and non-clinical populations.
  • Outline the hypothesized neurobiological mechanisms of how hallucinations emerge.
  • Explain the data on ketamine, esketamine, and psilocybin in management of depression.
  • Appraise the potential role of allopregnanolone derivatives in the treatment of postpartum and treatment-refractory depression.
  • Discuss current knowledge regarding the neuroanatomic and neurobiologic underpinnings of borderline personality disorder.
  • Integrate evidence-based data to diagnose and manage patients with borderline personality disorder.
  • Develop a strategy to manage patients with borderline personality disorder.
  • Compare current approaches to brain stimulation.
  • Strategize when and how to prescribe neurostimulation for refractory depression
  • Understand the psychological makeup of difficult patients.
  • Manage unpleasant patient situations and appropriately treat difficult patients
  • Diagnose and manage neuropsychiatric, behavioral, mood and anxiety symptoms/disorders in long-term care residents with and without dementia.
  • Utilize pharmacotherapy and non-pharmacotherapy, including the concept of de-prescribing, to enhance the quality of life of long-term care residents.
  • Apply scientific data relative to the utility of nutritional approaches such as the MIND Diet in Alzheimer disease for patients and their at-risk family members.
  • Explain the potential role of gut microbiota in neuro-inflammation and neuronal death in Alzheimer disease, and how to apply it to improve the health of Alzheimer disease patients.
  • Perform a differential diagnosis for attention deficit hyperactivity disorder across childhood, adolescence, and adulthood.
  • Develop treatment strategies for attention deficit hyperactivity disorder for patients across the lifespan, including combination treatment.
  • List the numerous stressors college students face and strategies to manage them.
  • Identify key mindset barriers in parents and youth that are important for clinicians to address.

 

INTERNATIONAL CREDIT DESIGNATION
European physicians can earn their ECMEC®s by attending live events worldwide that have been granted ECMEC®s through the UESMS-EACCME procedure, and worldwide, except in Europe, that have been certified for AMA PRA Category 1 Credits™. European physicians can also earn their ECMEC®s by completing e-learning programs from providers from all over the world except in the United States, that have been granted ECMEC®s through the UEMS-EACCME procedure and from accredited providers from the United States, that have been certified for AMA PRA Category 1 Credits™.
Additionally, the following Countries and Regions have reciprocity with the ACCME:
•    Royal College of Physicians and Surgeons of Canada (Canada)
•    Federation of Royal Colleges of Physicians (UK)
•    Bulgarian Union of Scientific Medical Societies (Bulgaria)
•    French National Medical Council (France)
•    Italian Federation of Scientific Medical Societies (Italy)
•    National CME Commission of the Italian Ministry of Health (Italy)
•    Spanish Accreditation Council for CME (Spain)
•    Bavarian Chamber of Physicians (Germany)

 

Follow Us